BIOCON
BIOCON LIMITED.Healthcare
LTP
426.35
CHG · %
-10.25 (-2.35%)
VOL · TODAY
52.66L
PREV CLOSE
436.6
Today's range425.3 · 436.2
426.35
52-week range331 · 447.15
426.35
Loading candles…
Biocon Ltd. is an India-based global biopharmaceutical company operating in the biotechnology and biopharmaceutical industries. The company focuses on developing and manufacturing affordable therapies for chronic diseases such as diabetes, oncology, and immunology. It operates through four main business segments: Generics, Biosimilars via its subsidiary Biocon Biologics, Research Services through its subsidiary Syngene, and Novel Biologics. Biocon employs a vertically integrated model managing the entire value chain from discovery to commercialization. Its products and services include biotechnology product manufacturing and research services. The company serves customers in over 120 countries worldwide.
- Market MoversGap DownStocks opening significantly below the previous close — indicates selling pressure or negative news
- MomentumShort BuildUpPrice fall with rising open interest — reflects bearish momentum
- Market MoversTop LosersStocks with the steepest declines — shows strong selling or negative sentiment
This page is a live market overview for BIOCON LIMITED. (BIOCON) on the NSE. As a listed security, BIOCON LIMITED. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BIOCON before placing trades on tick2trade.
As of the latest feed, BIOCON last traded at ₹426.35 on NSE, down ₹10.25 (2.35%) from the previous close of ₹436.6. Today's session range is ₹425.3 – ₹436.2, against a 52-week band of ₹331 – ₹447.15. Traded volume today stands at 52.66L shares.
The overview consolidates an interactive price chart with multiple time ranges, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for BIOCON in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BIOCON is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BIOCON LIMITED. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BIOCON. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BIOCON option chain page linked from this overview.
// similar in healthcare314 total